ArticleCureus2025
Impact of Prolonged Catheterization for Vesicourethral Leakage on Continence and Quality of Life After Robotic Prostatectomy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTo determine whether prolonged urinary catheterization due to vesicourethral anastomotic leakage (VAL) after robot-assisted radical prostatectomy (RARP) impacts urinary continence recovery and quality of life (QOL).
methodsWe retrospectively analyzed 360 patients who underwent transperitoneal RARP at a single institution from January 2022 to December 2024. All patients underwent cystography on postoperative day 6 or 7. Those with VAL requiring extended catheterization were compared with patients undergoing standard removal. Continence was assessed using Question 5 of the Expanded Prostate Cancer Index Composite (EPIC), and QOL was measured with the Functional Assessment of Cancer Therapy-General (FACT-G), FACT-Prostate (FACT-P), and the EPIC urinary subscale. Outcomes were evaluated up to 24 months postoperatively.
resultsVAL was detected in 36 patients (10.0%). Continence recovery did not differ significantly between the prolonged and standard catheter groups at 1, 6, or 12 months (63%, 89%, 92% vs. 54%, 85%, 93%, respectively). QOL outcomes were also comparable, although preoperative EPIC scores were lower in the prolonged catheter group. Multivariate analysis identified greater prostate specimen weight (p = 0.049) and intraoperative leakage (p = 0.002) as independent predictors of prolonged catheterization.
conclusionsProlonged urinary catheterization due to VAL after RARP does not adversely affect long-term urinary continence recovery or urinary-related QOL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.